Current Controversies in Lung Cancer Staging
Brett W Carter1, Myrna C B Godoy, Carol C Wu
1Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Journal of Thoracic Imaging
|June 17, 2016
Summary
The eighth edition of the tumor, node, and metastasis (TNM-8) staging system for lung cancer introduces significant revisions based on survival data. Understanding these changes is crucial for accurate lung cancer staging and improved patient treatment outcomes.
Area of Science:
- Oncology
- Radiology
- Thoracic Surgery
Background:
- Lung cancer is the leading cause of cancer mortality in the US.
- Accurate staging is vital for treatment planning and patient outcomes.
- The International Association for the Study of Lung Cancer proposed revisions to the TNM staging system.
Purpose of the Study:
- To outline the key changes in the eighth edition of the tumor, node, and metastasis (TNM-8) staging system for lung cancer.
- To highlight the impact of these revisions on lung cancer classification and patient management.
- To inform radiologists about TNM-8 limitations and potential controversies for accurate staging.
Main Methods:
- Analysis of a large international lung cancer database to identify survival differences.
- Revision of tumor (T), node (N), and metastasis (M) descriptors.
- Development of new stage groups and reassignment of existing ones.
Main Results:
- T descriptors modified by tumor size (1 cm increments).
- New groupings for atelectasis/pneumonitis and main bronchus involvement.
- Revisions to diaphragmatic invasion, mediastinal pleural invasion, and metastatic disease descriptors.
- Creation of new stage groups and shifts in existing ones.
Conclusions:
- TNM-8 represents an advancement in lung cancer staging, reflecting improved understanding of tumor behavior.
- Radiologists must understand TNM-8 revisions for precise patient staging.
- Awareness of TNM-8 limitations and controversies is essential for optimal treatment decisions.
